Osteoporosis drugs, BISPPHOSPHONATES, triple the risk of bone collapse: A Canadian study says:

A new Canadian study revealed that a popular class of osteoporosis drugs, Fosamax, Actonel, Didrocal, belong to ‘bisphosphonates’ triple the risk of developing a painful and disfiguring bone condition. I was surprised to read this news. A team from British Columbia researchers has found that bisphosphonates, a class of drugs used by millions of women worldwide to help prevent bone fractures due to osteoporosis, nearly triple the risk of developing ‘bone necrosis’ ( a condition that can lead to disfigurement and incapacitating pain, may lead to permanent loss of blood supply to the bones).
This research is the largest ever study of bone necrosis and bisphosphonates conducted by the University of British Columbia and Vancouver coastal Health research Institute.
It seems more than 190 million prescriptions have been written for bisphosphonates worldwide, according to the American Dental Association.

Let us see the reaction from Health Canada based on these studies.